Clinical Trials Browser

Phase 3 × durvalumab × Head & Neck × Clear all

NCT04116047 2024-07-29

CompARE

Phase 3 Active not recruiting

Oropharyngeal Neoplasms

NCT03673735 2021-05-10

ADHERE

Phase 3 Withdrawn

Squamous Cell Carcinoma of Head and Neck

NCT02369874 2021-02-10

EAGLE

Phase 3 Completed

736 enrolled 26 charts

Head and Neck Neoplasms, Recurrence